Trial Profile
A Phase 1 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Entinostat (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Syndax Pharmaceuticals
- 14 Apr 2017 Status changed from recruiting to completed.
- 27 Sep 2016 New trial record